CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$164,000
-56.4%
800,9000.0%0.00%
Q2 2019$376,000
+6.8%
800,9000.0%0.00%
Q1 2019$352,000
+41.4%
800,9000.0%0.00%
Q4 2018$249,000
-57.2%
800,9000.0%0.00%
-100.0%
Q3 2018$582,000
+69.2%
800,9000.0%0.00%
Q2 2018$344,000
-20.4%
800,9000.0%0.00%
-100.0%
Q1 2018$432,000
-18.5%
800,9000.0%0.00%0.0%
Q4 2017$530,000
+14.0%
800,9000.0%0.00%0.0%
Q3 2017$465,000
-30.7%
800,9000.0%0.00%0.0%
Q2 2017$671,000
-38.4%
800,9000.0%0.00%
-50.0%
Q1 2017$1,089,000
+205.9%
800,9000.0%0.00%
+100.0%
Q4 2016$356,000
-20.7%
800,9000.0%0.00%0.0%
Q3 2016$449,000
-12.5%
800,9000.0%0.00%0.0%
Q2 2016$513,000
-23.8%
800,9000.0%0.00%0.0%
Q1 2016$673,000
-17.6%
800,9000.0%0.00%0.0%
Q4 2015$817,000
-13.5%
800,9000.0%0.00%
-50.0%
Q3 2015$945,000
-39.5%
800,9000.0%0.00%0.0%
Q2 2015$1,562,000
+26.6%
800,900
+36.3%
0.00%0.0%
Q1 2015$1,234,0000.0%587,8000.0%0.00%0.0%
Q4 2014$1,234,000
+570.7%
587,800
+674.4%
0.00%
Q3 2014$184,000
-33.6%
75,9000.0%0.00%
Q2 2014$277,000
-18.8%
75,9000.0%0.00%
Q1 2014$341,000
+14.8%
75,9000.0%0.00%
Q4 2013$297,000
-13.7%
75,9000.0%0.00%
-100.0%
Q3 2013$344,000
+41.6%
75,900
+53.3%
0.00%
Q2 2013$243,00049,5000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,178,440$5,338,0005.83%
GREAT POINT PARTNERS LLC 399,007$1,808,0001.25%
Camber Capital Management LP 1,790,000$8,109,0000.85%
MENORA MIVTACHIM HOLDINGS LTD. 1,041,078$4,716,0000.43%
FEDERATED HERMES, INC. 10,427,472$47,237,0000.18%
SILVERBACK ASSET MANAGEMENT LLC 272,200$1,233,0000.10%
Catalyst Capital Advisors LLC 30,000$136,0000.07%
OBERWEIS ASSET MANAGEMENT INC/ 54,200$246,0000.07%
Baillie Gifford 5,548,351$25,134,0000.06%
Fore Research & Management, LP 200,000$906,0000.06%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders